# Cardinal Health (CAH) Q1 FY2027 earnings

Results filed 2026-11-05 for the quarter ended 2026-09-30. Source page: https://earnings.opennash.com/companies/cah/2027-q1/
Press release and documents: https://www.sec.gov/Archives/edgar/data/721371/000072137126000042/0000721371-26-000042-index.htm
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

Cardinal Health raised its fiscal 2027 outlook as brand and specialty pharma demand grew, a CVS Health distribution renewal was signed and a diabetes supplies acquisition was lined up.

Cardinal's pharmaceutical distribution business grew on brand and specialty drug sales from existing customers, helped by a better generics program. Its home-health, nuclear and logistics businesses (reported together as Other) grew across all three units. Medical products were flat: Cardinal Health Brand grew, but distribution and currency effects weighed. The company closed the Strive Medical acquisition, a multi-specialty supply provider focused on urology.
Management is leaning further into specialty, supporting community-based physicians with data, platform and distribution services, while continuing its Global Medical Products and Distribution improvement plan. Near-term deals include a binding letter of intent to renew CVS Health distribution agreements and the AdaptHealth Diabetes Health acquisition, expected in Q3. The main risks are branded drug pricing regulation, tariffs, the Iran conflict, generic deflation and Department of Justice investigations.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Revenue | $67.5 billion | up 5% from a year ago | GAAP |
| Operating earnings | $753 million | up 13% from a year ago | GAAP |
| Diluted EPS | $2.38 | up 27% from a year ago | GAAP |
| Non-GAAP diluted EPS | $3.26 | up 28% from a year ago | non-GAAP |
| Operating cash flow | $1,398 | up from $973 million a year ago | GAAP |
| Non-GAAP adjusted free cash flow | $1,583 | up from $1,285 million a year ago | non-GAAP |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Pharmaceutical and Specialty Solutions revenue | $62.6 billion | up 6% |
| Pharmaceutical and Specialty Solutions segment profit | $783 million | up 17% |
| Global Medical Products and Distribution revenue | $3.2 billion | approximately flat |
| Global Medical Products and Distribution segment profit | $33 million | down 28% |
| Other revenue | $1.8 billion | up 7% |
| Other segment profit | $193 million | up 16% |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Non-GAAP diluted EPS | fiscal year 2027 | $12.80 to $13.00 |
| Non-GAAP effective tax rate | fiscal year 2027 | 18.5% to 19.5% |
| Pharmaceutical and Specialty Solutions profit growth | fiscal year 2027 | 10% to 12% |
| Other profit growth | fiscal year 2027 | 17% to 20% |
| Other revenue growth | fiscal year 2027 | 12% to 14% |
| Capital expenditures | fiscal year 2027 | ~$700M |
| Non-GAAP adjusted free cash flow | fiscal year 2027 | $3.5B – $4.0B |

## Key takeaways

1. **CVS Health distribution agreements set for renewal** Cardinal signed a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health. This secures a long-standing relationship and enables continued volume growth in the largest segment.
2. **Brand and specialty drugs drive pharma growth** Pharmaceutical and Specialty Solutions grew on brand and specialty sales from existing customers, plus positive generics program performance. Management raised the segment's profit growth outlook to 10% to 12%.
3. **Specialty strategy centers on community physicians** Cardinal positions itself to support community-based physicians through MSO platforms, data and technology solutions, scaled contracting and distribution. Its slides cite approximately 60% of the multi-specialty and approximately 40% of the oncology market for platforms.
4. **Acquisitions broaden supply and home-health reach** Cardinal closed Strive Medical, a multi-specialty supply provider focused on urology, and expects to close AdaptHealth's Diabetes Health business in Q3 of fiscal 2027. Both extend its supply and at-home offerings.
5. **Medical products still lag despite brand growth** Global Medical Products and Distribution revenue was flat as Cardinal Health Brand growth was offset by lower distribution revenue. Management continues executing its improvement plan, with unfavorable distribution and foreign exchange hurting profit.

## Questions

**What drove growth in Cardinal Health's pharmaceutical segment?** Brand and specialty pharmaceutical sales growth from existing customers drove revenue, while brand and specialty products and positive generics program performance drove profit.
**What is happening with CVS Health?** Cardinal entered a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health, enabling continued volume growth in the Pharmaceutical and Specialty Solutions segment.
**Which acquisitions is Cardinal Health making?** It closed Strive Medical, a multi-specialty supply provider focused on urology, and expects to complete the purchase of AdaptHealth's Diabetes Health business in Q3 of fiscal 2027.
**How is Cardinal pursuing specialty and physician-practice strategy?** It is supporting community-based physicians with MSO platforms, analytics and real-world evidence, distribution and GPO offerings. It launched the INSIGHT-IBD real-world evidence study with Eli Lilly.
**What are the main risks to Cardinal's plan?** Management cites branded drug pricing regulation, tariffs, the Iran conflict, generic deflation, and Department of Justice investigations under the Anti-Kickback Statute and False Claims Act.

## Slides and investor documents

- [Presentation](https://s201.q4cdn.com/566741227/files/content_files/Q1-FY27-Earnings-Presentation-FINAL.pdf) (Slide deck)
- [Transcript](https://s201.q4cdn.com/566741227/files/content_files/Q1-FY27-CAH-Earnings-Transcript.pdf) (Company's official transcript)
- [Webcast](https://events.q4inc.com/attendee/706194842) (Webcast replay)
- [Form 10-Q](https://s201.q4cdn.com/566741227/files/content_files/10-Q.pdf) (Document)

